Pharmapack Europe 2020 award winners announced
The winners from the 2020 Pharmapack Awards have been announced, with eight awards granted across two categories in the pharmaceutical packaging and drug delivery industries.
List view / Grid view
The winners from the 2020 Pharmapack Awards have been announced, with eight awards granted across two categories in the pharmaceutical packaging and drug delivery industries.
Experts in the UK have called for government action to resolve the shortages of hormone replacement therapy and now contraceptives.
The first US in-human trial of CRISPR-Cas9-edited T cells has concluded with no ill effects and showed that nine months later the infused cells were still active against cancer.
Mavidon has recalled LemonPrep, PediaPrep, Wave Prep and Cardio Prep due to the products being potentially contaminated with Burkholderia cepacia.
The US FDA has approved AUDENZ, a vaccine formulated with MF59® adjuvant, as an Influenza A H5N1 vaccine that can be quickly deployed in the event of a pandemic.
A report suggests the need for novel therapies and cost-effective R&D will drive growth for contract research organisations, especially in Asia-Pacific.
The EMA has released a statement on its efforts to support the development of a treatment for the novel coronavirus (2019-nCoV).
The results of a clinical study for a gestational malaria vaccine has shown that the treatment is "well tolerated" and can produce an immune response.
Medreich Plc is recalling a number of ranitidine products due to possible contamination with an impurity N-nitrosodimethylamine (NDMA).
Researchers have found that the development and evaluation of new treatments received the most funding in the UK over the past 14 years.
A patch the size of a coin has been created by researchers as a way to detect glucose levels in the blood and deliver insulin when required.
The US NIAID has stopped its HVTN 702 clinical trial for an HIV vaccine after an independent board found that the treatment did not prevent the condition.
An innovation in hydrogels has created a portable, reusable chemical-producing platform that could provide access to essential pharmaceuticals without specialised storage requirements.
A written statement from the UK government has highlighted the importance of trade co-operation with the EU, including for pharmaceuticals.
The developers of DSP-1181, a drug created using AI, announced that it has entered a Phase I clinical trial for the treatment of obsessive-compulsive disorder (OCD).